Mark Kozloff to Filgrastim
This is a "connection" page, showing publications Mark Kozloff has written about Filgrastim.
Connection Strength
0.038
-
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
Score: 0.038